Jade Biosciences, Inc. Shares Outstanding (Cover Page)
Jade Biosciences, Inc. (JBIO) had Shares Outstanding (Cover Page) of 63.60 million shares as of 2026-08-03, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-03: Entity Common Stock, Shares Outstanding 63.60M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 49.36M shares.
- 2026-02-28: Entity Common Stock, Shares Outstanding 49.32M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 46.00M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 63.60M shares 10-Q · filed 2026-08-10 |
| 2026-05-01 | 49.36M shares 10-Q · filed 2026-05-07 |
| 2026-02-28 | 49.32M shares 10-K · filed 2026-03-06 |
| 2025-11-07 | 46.00M shares 10-Q · filed 2025-11-14 |
| 2025-08-08 | 32.63M shares 10-Q · filed 2025-08-13 |
| 2025-04-24 | 28.99M shares 10-Q · filed 2025-04-25 |
| 2025-03-24 | 28.99M shares 10-K · filed 2025-03-27 |
| 2024-11-08 | 28.87M shares 10-Q · filed 2024-11-12 |
| 2024-08-09 | 28.87M shares 10-Q · filed 2024-08-12 |
| 2024-05-09 | 28.81M shares 10-Q · filed 2024-05-13 |
| 2024-03-21 | 27.86M shares 10-K · filed 2024-03-25 |
| 2023-11-09 | 27.67M shares 10-Q · filed 2023-11-13 |
| 2023-08-10 | 27.65M shares 10-Q · filed 2023-08-14 |
| 2023-05-10 | 24.92M shares 10-Q · filed 2023-05-15 |
| 2023-03-27 | 24.81M shares 10-K · filed 2023-03-29 |
| 2022-11-10 | 24.61M shares 10-Q · filed 2022-11-14 |
| 2022-08-11 | 24.45M shares 10-Q · filed 2022-08-15 |
| 2022-05-13 | 24.41M shares 10-Q · filed 2022-05-16 |
| 2022-03-29 | 24.41M shares 10-K · filed 2022-03-30 |
| 2021-11-12 | 24.41M shares 10-Q · filed 2021-11-15 |
| 2021-08-13 | 24.41M shares 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |